e-learning
resources
Vienna 2009
Monday, 14.09.2009
From bench to bedside: diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of rapid test device based on detection of antibodies against 6,16 and 38 kDa antigens of mycobacterium tuberculosis
P. Baghaei Shiva, P. Tabarsi, M. Marjani, S. Dehghani, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Session:
From bench to bedside: diagnosis of tuberculosis
Session type:
E-Communication Session
Number:
1684
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Baghaei Shiva, P. Tabarsi, M. Marjani, S. Dehghani, M. R. Masjedi (Tehran, Islamic Republic Of Iran). Evaluation of rapid test device based on detection of antibodies against 6,16 and 38 kDa antigens of mycobacterium tuberculosis. Eur Respir J 2009; 34: Suppl. 53, 1684
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Evaluation of a IFN-γ test using
Mycobacterium tuberculosis
-specific antigens for diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006
Evaluation of a rapid bactriophage assay for the detection of
mycobacterium tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Performance of five serological tests using different antigens in rapid diagnosis of tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay
Source: Eur Respir J 2007; 29: 1212-1216
Year: 2007
Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptides
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary
Mycobacterium avium-intracellulare
complex (MAC) disease
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Source: Eur Respir J 2006; 28: 16-23
Year: 2006
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay
Source: Eur Respir J 2007; 29: 605-607
Year: 2007
The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003
A pilot study of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of nontuberculous mycobacterial infections.
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Deficient
in silico
selection of
mycobacterium tuberculosis
(MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex pulmonary disease
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept